Cygnus Biosciences (Beijing) Co., Ltd.

Cygnus Biosciences (Beijing) Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttp://www.cygnusbio.com

Last Round

Series C

Extension

Mar 20, 2023

Total Funding Raised

$70.71M

Company Overview

Cygnus Biosciences (Beijing) Co., Ltd. is a biotechnology company that develops, produces, and markets gene sequencing technology, including instruments, reagents, and services for fields such as medical diagnosis and drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Precision Medicine, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

gene sequencersnext-generation sequencingNGSgene sequencingsequencing reagentsDNA sequencingsequencing platformgenetic testing serviceshigh-throughput sequencingError-Correction Code sequencingECC sequencinggenomics platformsequencing consumableslife science toolsmedical diagnosticsrazor-and-blades modeldrug developmentFluorogenic sequencing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cygnus Biosciences (Beijing) Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cygnus Biosciences (Beijing) Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionMar 20, 2023
Series CJun 11, 2020
Series B ExtensionMay 28, 2018
Series BNov 14, 2017
Series ANov 10, 2015

Cygnus Biosciences (Beijing) Co., Ltd. Investors

Notable investors and investment history

InvestorRounds
Source Code CapitalSeries C Extension
THG VenturesSeries B Extension
Zhongguancun Development GroupSeries B
Founder Hesheng Investment Co., Ltd.Series C Extension

Cygnus Biosciences (Beijing) Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cygnus Biosciences (Beijing) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cygnus Biosciences (Beijing) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range18
Year Founded2015
Last FundingMar 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.